Global Patent Index - EP 1390073 A2

EP 1390073 A2 20040225 - COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS

Title (en)

COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS

Title (de)

ZUSAMMENSETZUNGEN MIT VERBESSERTEN PHARMAKOKINETISCHEN EIGENSCHAFTEN

Title (fr)

COMPOSITIONS AYANT DES CARACTERISTIQUES PHARMACOCINETIQUES AMELIOREES

Publication

EP 1390073 A2 20040225 (EN)

Application

EP 02725939 A 20020503

Priority

  • US 0214241 W 20020503
  • US 84793501 A 20010503
  • US 13624002 A 20020501

Abstract (en)

[origin: WO02089853A2] Compositions comprising a therapeutic component and an efficacy enhancing component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The therapeutic component may include an alpha-2-adrenergic agonist and the efficacy enhancing component may include fatty acids. In one embodiment, the therapeutic component and the efficacy enhancing component form a complex.

IPC 1-7

A61K 47/48; A61P 27/06

IPC 8 full level

A61K 47/12 (2006.01); A61K 31/498 (2006.01); A61K 45/00 (2006.01); A61K 47/28 (2006.01); A61K 47/30 (2006.01); A61K 47/48 (2006.01); A61P 3/10 (2006.01); A61P 27/06 (2006.01)

CPC (source: EP)

A61K 31/498 (2013.01); A61K 47/542 (2017.07); A61K 47/58 (2017.07); A61P 3/10 (2017.12); A61P 27/06 (2017.12)

Citation (search report)

See references of WO 02089853A2

Citation (examination)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 02089853 A2 20021114; WO 02089853 A3 20031211; AU 2002256471 B2 20070524; CA 2446705 A1 20021114; CA 2446705 C 20120306; EP 1390073 A2 20040225; JP 2004528369 A 20040916

DOCDB simple family (application)

US 0214241 W 20020503; AU 2002256471 A 20020503; CA 2446705 A 20020503; EP 02725939 A 20020503; JP 2002586985 A 20020503